Prytime Medical Devices, Inc., an innovative medical device company, designs, develops and commercializes minimally invasive solutions for hemorrhage control. The companys flagship product is the ER-REBOA Catheter, a 7 Fr compatible balloon catheter designed specifically for rapid, temporary occlusion of large vessels in the emergency and critical care environment during the REBOA (Resuscitative Endovascular Occlusion of the Aorta) procedure. The underlying intellectual property for the ER-REBOA Catheter was conceived by experienced military vascular and trauma surgeons, COL. Todd Rasmussen and Dr. Jonathan Eliason, based on lessons learned on the battlefront during combat. The first guidewire free prototype was developed and tested on animals in 2011. Shortly thereafter the company was founded. In October 2015 the ER-REBOA Catheter received 510(K) clearance and we began commercializing the device the US market in 2016, followed by the European market. Now approved in Canada as well, use of the device is increasing worldwide, with the total number of hospitals using the ER-REBOA Catheter now exceeding 250. The initial market for the device is trauma, with a strong pull developing in adjacent markets including cardiac arrest, postpartum hemorrhage, interventional radiology, perisurgical and pre-hospital in the US and abroad. At Prytime, we are proud to be a part of bringing military medical innovation to the civilian marketplace. We believe that no one should bleed to death; and the sooner you stop bleeding, the better.